scholarly article | Q13442814 |
P50 | author | Naoko Sanuki | Q43569014 |
Atsuya Takeda | Q86664504 | ||
P2093 | author name string | Takeshi Kaneko | |
Yu Hara | |||
Takahisa Eriguchi | |||
Tatsuji Enomoto | |||
Tomikazu Mizuno | |||
Yuichiro Tsurugai | |||
Hidehiko Kuribayashi | |||
Yusuke Saigusa | |||
Atsuya Narita | |||
Kae Yashiro | |||
P2860 | cites work | Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups | Q30438068 |
Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT). | Q30450883 | ||
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). | Q33401383 | ||
The prognostic factors of resected non-small cell lung cancer with chest wall invasion | Q35768959 | ||
Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients. | Q35824260 | ||
Stereotactic body radiotherapy for T3 and T4N0M0 non-small cell lung cancer. | Q37025540 | ||
The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy | Q37178916 | ||
Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines | Q38104632 | ||
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline | Q38735528 | ||
Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer | Q38825198 | ||
Cancer Statistics, 2017. | Q39038674 | ||
Trends in stereotactic body radiation therapy for stage I small cell lung cancer. | Q39063807 | ||
Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer. | Q39188702 | ||
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC | Q39692515 | ||
Investigation of the freely available easy-to-use software 'EZR' for medical statistics | Q41513106 | ||
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. | Q43445849 | ||
Modern surgical results of lung cancer involving neighboring structures: a retrospective analysis of 531 pT3 cases in a Japanese Lung Cancer Registry Study | Q43532145 | ||
The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC). | Q44554165 | ||
Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database | Q44667329 | ||
Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category? | Q44731252 | ||
The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer | Q45185961 | ||
Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline | Q46205940 | ||
Relationship of tumor size to survival in patients with pT2N0 lung cancer | Q47352301 | ||
Practice Patterns and Outcomes in Elderly Stage I Non-Small-cell Lung Cancer: A 2004 to 2012 SEER Analysis. | Q47363648 | ||
Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance | Q47604097 | ||
Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial | Q47932143 | ||
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. | Q48622865 | ||
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer | Q49014865 | ||
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. | Q51061126 | ||
Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy. | Q51832036 | ||
Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis. | Q53666224 | ||
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† | Q59587188 | ||
Resection of chest wall invasion in patients with non-small cell lung cancer | Q80997806 | ||
A planning comparison of 3-dimensional conformal multiple static field, conformal arc, and volumetric modulated arc therapy for the delivery of stereotactic body radiotherapy for early stage lung cancer | Q85263213 | ||
Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy | Q87534007 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P304 | page(s) | 639-649 | |
P577 | publication date | 2019-10-01 | |
P1433 | published in | Journal of Radiation Research | Q2330802 |
P1476 | title | Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure | |
P478 | volume | 60 |
Search more.